News & Events

Research highlights

February 24, 2017

New Gene Sequencing Software Could Aid in Early Detection and Treatment of Cancer

Winston Timp, an assistant professor of biomedical engineering, supervised research on new computational software that determines if a human DNA sample includes an epigenetic add-on linked to cancer and other health conditions.

Read on.

New Peptide Could Improve Treatment for Vision-Threatening Disease

January 26, 2017

New Peptide Could Improve Treatment for Vision-Threatening Disease

Johns Hopkins researchers report that a new peptide holds promise for improving treatment for degenerative retinal diseases, such as age-related macular degeneration, diabetic macular edema and diabetic retinopathy. These vascular diseases often result in central vision loss as blood vessels grow into tissues at the back of the eye, where such growth should not occur.

Read on.

January 23, 2017

Noninvasive Ultrasound Pulses Used to Precisely Tweak Rat Brain Activity

Jordan Green, associate professor of biomedical engineering, and his colleagues have figured out a noninvasive way to release and deliver concentrated amounts of a drug to the brain of rats in a temporary, localized manner using ultrasound.

Read on.

January 19, 2017

Potentially Reversible Changes in Gene Control ‘Prime’ Pancreatic Cancer Cells to Spread

A multicenter team of researchers reports that a full genomic analysis of tumor samples from a small number of people who died of pancreatic cancer suggests that chemical changes to DNA that do not affect the DNA sequence itself yet control how it operates confer survival advantages on subsets of pancreatic cancer cells. Those advantages, the researchers say, let such cancer cells thrive in organs like the liver and lungs, which receive a sugar-rich blood supply.

Read on.

January 11, 2017

New type of CT scanner approved by FDA

Jeffrey Siewerdsen, professor of biomedical engineering, and a team of researchers have designed a new type of CT scanner that has recently been approved for commercial use by the U.S. Food and Drug Administration.

Read on.

Michael Miller: Catching Alzheimer’s Early

Michael Miller, the Herschel and Ruth Sedar Professor of Biomedical Engineering and University Gilman Scholar, is analyzing MRI brain images of the elderly to unveil lurking signs of Alzheimer’s that cognitive tests cannot detect.

Read on.

Tumor Cells

January 7, 2017

Green and Schneck develop a strategy to lengthen lives of mice with skin cancer

Jordan Green, associate professor of biomedical engineering, and Jonathan Schneck, professor of pathology, both at the School of Medicine, have learned that by combining a biomimetic particle along with a more traditional immunotherapy they could lengthen the lives of mice with skin cancer better than either treatment alone. Both approaches focus on activating the rodent immune system killer T cells — white blood cells that fight infection and other invaders.

Read on.

December 16, 2016

New bioinformatics tool tests methods for finding mutant genes that ‘drive’ cancer

In their search for new ways to treat cancer, many scientists are using a high-tech process called genome sequencing to hunt for genetic mutations that encourage tumor cells to thrive. To aid in this search, some researchers have developed new bioinformatics methods that each claim to help pinpoint the cancer-friendly mutants.

Read on.

Recent PhD graduate Jennifer Xu

November 21, 2016

Jennifer Xu and the I-STAR Lab Reach Major Milestone in Cone-Beam CT

Recent PhD graduate from Johns Hopkins Biomedical Engineering, Jennifer Xu, reached an important milestone in translating her research from the laboratory to first clinical studies of a new point-of-care cone-beam CT (CBCT) scanner.

Read on.

November 4, 2016

Visualizing blood flow in the heart could help reduce the risk of stroke

New computer models that track the motions of blood flow in the heart may reduce the risk of stroke, according to researchers at Johns Hopkins Medicine.

Read on.